Evaluation of Skin Cleansers and Skin Protectants in Management of Incontinence-associated Dermatitis

Evaluate the Efficacy of Two Advanced Skin Treatment Regimens in Treating Incontinence-associated Dermatitis: Cluster Randomization Study

The aim of this study is to evaluate the efficacy of two different skin care regimens (3M Cavilon Advanced Skin Protectant with 3M No-Rinse Cleanser and Coloplast Conveen Critic Barrier with Easi-Cleanser) against standard care (Skin wipes and Conveen Critic Barrier) in the management of Incontinence-Associated Dermatitis (IAD) in hospitalised patients

The aim of this study is to evaluate the efficacy of two different skin care regimens (3M Cavilon Advanced Skin Protectant with 3M No-Rinse Cleanser and Coloplast Conveen Critic Barrier with Easi-Cleanser) against standard care (Skin wipes and Conveen Critic Barrier) in the management of Incontinence-Associated Dermatitis (IAD) in hospitalised patients.

To date, there is no conclusive evidence on the "best treatment" for patients presenting with IAD. This has led to current clinical practices tend to select IAD products based on its cost and availability, which can be heavily influenced by marketing and commercialisation efforts.

This study allows investigation of the effectiveness of IAD products to ensure the provision of optimal care.

Inclusion Criteria:

• Aged 21 years and above at point of recruitment
• Diagnosed with IAD
• At regular risk of exposure to urine and faeces over their hospitalization

Exclusion Criteria:

• Having a known allergy to the treatment products
• Haemodynamically unstable at point of assessment for study
• Unable to tolerate lateral positioning for skin cleansing and treatment application
• Pregnancy
• Having an existing skin disease at point of study that might lead to inaccurate IAD assessment, such as herpes or scabies.